Sirona Biochem Receives Up-front Payment for Right of First Refusal Contract for Skin Lightener TFC-1067
Sirona Biochem Releases CEO Letter to Shareholders – Clinical trial results expected Q1 2019
Sirona Biochem’s SGLT2 Inhibitor in Testing for Animal Health
Sirona Biochem Begins Proof of Efficacy Clinical Trial for TFC-1067
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 29
- Next Page »